The International Journal Anticancer Intelligence.

The International Journal of Anticancer Intelligence is an open-access, peer-reviewed publication of the International Cancer Artificial Intelligence Research Institute (ICAIRI), dedicated to advancing rigorous research at the intersection of artificial intelligence, computational oncology, and cancer medicine. Anticancer Intelligence publishes original research articles, systematic reviews, methodological papers, and case studies across six thematic sections: AI Methods for Cancer Research (AIM), Cancer Genomics and Multi-omics (CGM), Cancer Imaging and Pathology (CIP), AI-driven Drug Discovery (ADD), Clinical Oncology and Decision Support (COD), and Reviews and Tutorials (REV). The journal employs single-blind peer review by expert researchers and clinicians, ensuring scientific rigor while maintaining rapid publication timelines. Anticancer Intelligence is indexed by Crossref for digital object identifiers (DOIs) and operates under a CC BY 4.0 open-access license, making all published research freely available to the global research community. By providing a dedicated venue for AI-oncology research—a field currently fragmented across interdisciplinary journals—Anticancer Intelligence accelerates knowledge translation, supports evidence-based algorithm validation, and bridges computational innovation with translational and clinical applications. The journal serves as the institutional flagship for ICAIRI’s mission to advance international cooperation in cancer AI research through accessible, peer-reviewed publication and methodological excellence.